Prevent Maternal Mortality Using Mobile Technology

NCT05339867 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2022-04-21

No results posted yet for this study

Summary

Black women who reside in a rural area are at highest risk for maternal morbidity and mortality due to a combination of social and structural causes. The postpartum period is the most critical yet most neglected phase for preventing suboptimal or fatal maternal health outcomes. The goal of this project is to use a mobile app to provide personalized support and improve the lives of women during the early postpartum period. The information the study team gathers will help educate women and all who support them about the need to seek postpartum care and the impact postpartum care can have on pregnancy-related complications. Participation in this research requires taking part in a focus group discussion which will allow participants to share or the person that supports the participant's story and experience with postpartum complications and willingness to use and desired features of a postpartum mobile app.

Conditions

  • Post-Partum

Interventions

BEHAVIORAL

Prevent Maternal Mortality using Mobile technology (PM3)

PM3: The app will include: 1. integrated self-management and tailored health messaging feature 2. support center based on social support gaps which will also provide a centralized place for identifying healthcare providers and facilities 3. multimedia resource kit comprised of videos, current events, news feeds, podcasts, and support groups related to women's postpartum health and community resources 4. a feature that will update women on maternal and reproductive health policies that impact women.

Sponsors & Collaborators

  • Emory University

    lead OTHER

Principal Investigators

  • Natalie Hernandez, PhD · Assistant Professor

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-22
Primary Completion
2023-03-31
Completion
2023-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05339867 on ClinicalTrials.gov